Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
As the number of biocompatible metals available for injection molding increases, the process is becoming a practical option for manufacturers of implants and surgical instruments. John L. Johnson ...
Manufacturing snags at Hospira, a unit of Pfizer, are helping create shortages of a wide range of injectable drugs, some of which have been voluntarily recalled by the company, the US Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results